Ramat Gan, Israel

Boaz Inbal

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Anima Biotech Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Boaz Inbal. Retrieved from https://idiyas.com/inventor/boaz-inbal-4aw3bd67

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Boaz Inbal: Innovator in Cancer Treatment

Introduction

Boaz Inbal is a notable inventor based in Ramat Gan, Israel. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on the modulation of c-MYC mRNA translation, which has important implications for cancer therapies.

Latest Patents

Inbal holds a patent for "c-MYC mRNA translation modulators and uses thereof in the treatment of cancer." This invention relates to novel c-MYC mRNA translation modulators, compositions, and methods of preparation, as well as their applications in treating cancer. His patent represents a significant advancement in the fight against this disease.

Career Highlights

Boaz Inbal is currently associated with Anima Biotech Inc., where he continues to push the boundaries of cancer research. His expertise in mRNA translation modulation has positioned him as a key player in the biotechnology sector.

Collaborations

Inbal has collaborated with notable colleagues, including Aviad Mandabi and Scott Alexander Sadler. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Boaz Inbal's contributions to cancer treatment through his patented innovations highlight his role as a leading inventor in the biotechnology field. His work continues to inspire advancements in medical research and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…